Belisari, A. et al. 2016. [Budget impact analysis of idarucizumab for the management of patients treated with dabigatran in emergency / urgent situations in Italy]. Farmeconomia. Health economics and therapeutic pathways. 17, 2 (Jun. 2016), 47–58. DOI:https://doi.org/10.7175/fe.v17i2.1243.